Published in EMBO J on February 01, 1991
DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev (1997) 9.69
All tangled up: how cells direct, manage and exploit topoisomerase function. Nat Rev Mol Cell Biol (2011) 2.66
Cloning and nucleotide sequence of Pseudomonas aeruginosa DNA gyrase gyrA gene from strain PAO1 and quinolone-resistant clinical isolates. Antimicrob Agents Chemother (1994) 2.47
Posttranslational modifications in microcin B17 define an additional class of DNA gyrase inhibitor. Proc Natl Acad Sci U S A (1994) 2.10
Ser-127-to-Leu substitution in the DNA gyrase B subunit of Streptococcus pneumoniae is implicated in novobiocin resistance. J Bacteriol (1995) 2.06
Intrinsic resistance of Mycobacterium smegmatis to fluoroquinolones may be influenced by new pentapeptide protein MfpA. Antimicrob Agents Chemother (2001) 2.02
Exploiting bacterial DNA gyrase as a drug target: current state and perspectives. Appl Microbiol Biotechnol (2011) 1.85
Pentapeptide repeat proteins. Biochemistry (2006) 1.68
Thiazole/oxazole-modified microcins: complex natural products from ribosomal templates. Curr Opin Chem Biol (2011) 1.67
An unusual mechanism for resistance to the antibiotic coumermycin A1. Proc Natl Acad Sci U S A (1991) 1.57
DNA sequence and mutational analysis of genes involved in the production and resistance of the antibiotic peptide trifolitoxin. J Bacteriol (1993) 1.36
Selectivity, directionality, and promiscuity in peptide processing from a Bacillus sp. Al Hakam cyclodehydratase. J Am Chem Soc (2012) 1.31
Nucleotide sequence of the Escherichia coli regulatory gene mprA and construction and characterization of mprA-deficient mutants. J Bacteriol (1991) 1.30
The role of antimicrobial peptides in preventing multidrug-resistant bacterial infections and biofilm formation. Int J Mol Sci (2011) 1.23
In vitro characterization of DNA gyrase inhibition by microcin B17 analogs with altered bisheterocyclic sites. Proc Natl Acad Sci U S A (2001) 1.23
The structural gene for microcin H47 encodes a peptide precursor with antibiotic activity. Antimicrob Agents Chemother (1999) 1.21
Genetic analysis of the Rhizobium meliloti bacA gene: functional interchangeability with the Escherichia coli sbmA gene and phenotypes of mutants. J Bacteriol (1997) 1.21
Ribosomally synthesized and post-translationally modified peptide natural products: new insights into the role of leader and core peptides during biosynthesis. Chemistry (2013) 1.15
ENPDA: an evolutionary structure-based de novo peptide design algorithm. J Comput Aided Mol Des (2005) 1.05
Characterization of two potentially universal turn motifs that shape the repeated five-residues fold--crystal structure of a lumenal pentapeptide repeat protein from Cyanothece 51142. Protein Sci (2006) 1.05
A newly discovered gene, tfuA, involved in the production of the ribosomally synthesized peptide antibiotic trifolitoxin. J Bacteriol (1996) 1.05
GyrI: a counter-defensive strategy against proteinaceous inhibitors of DNA gyrase. EMBO Rep (2002) 1.04
The highly conserved TldD and TldE proteins of Escherichia coli are involved in microcin B17 processing and in CcdA degradation. J Bacteriol (2002) 1.03
Biosynthetic tailoring of microcin E492m: post-translational modification affords an antibacterial siderophore-peptide conjugate. J Am Chem Soc (2007) 1.02
Extreme antimicrobial Peptide and polymyxin B resistance in the genus burkholderia. Front Microbiol (2011) 0.98
Orchestration of enzymatic processing by thiazole/oxazole-modified microcin dehydrogenases. Biochemistry (2014) 0.98
ATP synthase is necessary for microcin H47 antibiotic action. Antimicrob Agents Chemother (2001) 0.98
Glycosylated flavones as selective inhibitors of topoisomerase IV. Antimicrob Agents Chemother (1997) 0.97
In vivo titration of mitomycin C action by four Escherichia coli genomic regions on multicopy plasmids. J Bacteriol (2001) 0.95
The proton channel is the minimal structure of ATP synthase necessary and sufficient for microcin h47 antibiotic action. Antimicrob Agents Chemother (2003) 0.94
Construction and characterization of mutations at codon 751 of the Escherichia coli gyrB gene that confer resistance to the antimicrobial peptide microcin B17 and alter the activity of DNA gyrase. J Bacteriol (2001) 0.91
Extreme antimicrobial peptide and polymyxin B resistance in the genus Burkholderia. Front Cell Infect Microbiol (2011) 0.90
A major portion of DNA gyrase inhibitor microcin B17 undergoes an N,O-peptidyl shift during synthesis. J Biol Chem (2011) 0.89
Mechanism of inhibition of DNA gyrase by cyclothialidine, a novel DNA gyrase inhibitor. Antimicrob Agents Chemother (1994) 0.88
Using Bacterial Genomes and Essential Genes for the Development of New Antibiotics. Biochem Pharmacol (2016) 0.84
Targeted Treatment for Bacterial Infections: Prospects for Pathogen-Specific Antibiotics Coupled with Rapid Diagnostics. Tetrahedron (2015) 0.82
Microcin B17: posttranslational modifications and their biological implications. Proc Natl Acad Sci U S A (1994) 0.81
Structure of microcin B-like compounds produced by Pseudomonas syringae and species specificity of their antibacterial action. J Bacteriol (2013) 0.80
Mode of action of GR122222X, a novel inhibitor of bacterial DNA gyrase. Antimicrob Agents Chemother (1996) 0.80
YcaO-Dependent Posttranslational Amide Activation: Biosynthesis, Structure, and Function. Chem Rev (2017) 0.79
Antibiotic resistance in Salmonella enterica serovar Typhimurium exposed to microcin-producing Escherichia coli. Appl Environ Microbiol (2001) 0.79
Ribosome-controlled transcription termination is essential for the production of antibiotic microcin C. Nucleic Acids Res (2014) 0.78
Mechanism of bactericidal activity of microcin L in Escherichia coli and Salmonella enterica. Antimicrob Agents Chemother (2010) 0.77
The C-terminal part of microcin B is crucial for DNA gyrase inhibition and antibiotic uptake by sensitive cells. J Bacteriol (2014) 0.75
Intracellular Targeting Mechanisms by Antimicrobial Peptides. Antimicrob Agents Chemother (2017) 0.75
A hisT::Tn5 mutation affects production of microcins B17, C7, and H47 and colicin V. J Bacteriol (1991) 0.75
Protective Effect of Qnr on Agents Other than Quinolones That Target DNA Gyrase. Antimicrob Agents Chemother (2015) 0.75
Synthesis of fluorescent dipeptidomimetics and their ribosomal incorporation into green fluorescent protein. Bioorg Med Chem Lett (2015) 0.75
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
Linkage map of Escherichia coli K-12, edition 8. Microbiol Rev (1990) 18.60
Nalidixic acid resistance: a second genetic character involved in DNA gyrase activity. Proc Natl Acad Sci U S A (1977) 18.37
Mechanism of action of nalidixic acid: purification of Escherichia coli nalA gene product and its relationship to DNA gyrase and a novel nicking-closing enzyme. Proc Natl Acad Sci U S A (1977) 14.75
DNA topoisomerases. Annu Rev Biochem (1981) 13.42
DNA topoisomerases. Annu Rev Biochem (1985) 13.01
Novobiocin and coumermycin inhibit DNA supercoiling catalyzed by DNA gyrase. Proc Natl Acad Sci U S A (1976) 12.30
DNA gyrase and the supercoiling of DNA. Science (1980) 7.28
Energy coupling in DNA gyrase and the mechanism of action of novobiocin. Proc Natl Acad Sci U S A (1978) 6.33
Quinolone-resistant mutations of the gyrA gene of Escherichia coli. Mol Gen Genet (1988) 6.30
Nalidixic acid-resistant mutations of the gyrB gene of Escherichia coli. Mol Gen Genet (1986) 5.95
DNA gyrase: subunit structure and ATPase activity of the purified enzyme. Proc Natl Acad Sci U S A (1978) 5.60
Purification of subunits of Escherichia coli DNA gyrase and reconstitution of enzymatic activity. Proc Natl Acad Sci U S A (1978) 5.33
Biology of bacterial deoxyribonucleic acid topoisomerases. Microbiol Rev (1984) 5.10
Cloning and sequencing of the Escherichia coli gyrA gene coding for the A subunit of DNA gyrase. J Mol Biol (1987) 4.66
Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. Science (1984) 4.52
DNA gyrase: purification and catalytic properties of a fragment of gyrase B protein. Proc Natl Acad Sci U S A (1979) 4.34
Isolation and characterisation of a strain carrying a conditional lethal mutation in the cou gene of Escherichia coli K12. Mol Gen Genet (1979) 3.74
Inhibitors of DNA topoisomerases. Biochemistry (1988) 3.69
DNA gyrase on the bacterial chromosome: DNA cleavage induced by oxolinic acid. J Mol Biol (1979) 3.43
The export of the DNA replication inhibitor Microcin B17 provides immunity for the host cell. EMBO J (1988) 3.25
In vivo DNA cloning and adjacent gene fusing with a mini-Mu-lac bacteriophage containing a plasmid replicon. Proc Natl Acad Sci U S A (1984) 3.10
Cloning and simplified purification of Escherichia coli DNA gyrase A and B proteins. J Biol Chem (1984) 2.98
DNA sequence of the E. coli gyrB gene: application of a new sequencing strategy. Nucleic Acids Res (1987) 2.93
DNA gyrase binds to the family of prokaryotic repetitive extragenic palindromic sequences. Proc Natl Acad Sci U S A (1988) 2.86
Microcin plasmids: a group of extrachromosomal elements coding for low-molecular-weight antibiotics in Escherichia coli. J Bacteriol (1978) 2.83
Recent studies of DNA topoisomerases. Biochim Biophys Acta (1987) 2.65
DNA topoisomerase I mutants. Increased heterogeneity in linking number and other replicon-dependent changes in DNA supercoiling. J Mol Biol (1985) 2.40
A topoisomerase from Escherichia coli related to DNA gyrase. Proc Natl Acad Sci U S A (1979) 2.29
Nucleotide sequence of the osmoregulatory proU operon of Escherichia coli. J Bacteriol (1989) 2.26
DNA sequence, products, and transcriptional pattern of the genes involved in production of the DNA replication inhibitor microcin B17. J Bacteriol (1989) 2.07
Cloning and mapping of the genetic determinants for microcin B17 production and immunity. J Bacteriol (1985) 1.90
Structure of the Drosophila DNA topoisomerase II gene. Nucleotide sequence and homology among topoisomerases II. J Mol Biol (1989) 1.89
Microcin B17 blocks DNA replication and induces the SOS system in Escherichia coli. J Gen Microbiol (1986) 1.89
Interaction between DNA gyrase and its cleavage site on DNA. J Biol Chem (1980) 1.82
The DNA replication inhibitor microcin B17 is a forty-three-amino-acid protein containing sixty percent glycine. Proteins (1986) 1.80
Identification, mapping, cloning and characterization of a gene (sbmA) required for microcin B17 action on Escherichia coli K12. J Gen Microbiol (1986) 1.79
Plasmid genes required for microcin B17 production. J Bacteriol (1985) 1.59
Characterization of an improved in vitro DNA replication system for Escherichia coli plasmids. Nucleic Acids Res (1979) 1.54
The 52-protein subunit of T4 DNA topoisomerase is homologous to the gyrA-protein of gyrase. Nucleic Acids Res (1986) 1.42
In vivo transcription of R-plasmid deoxyribonucleic acid in Escherichia coli strains with altered antibiotic resistance levels and/or conjugal proficiency. J Bacteriol (1976) 1.34
Nucleotide sequence of a type II DNA topoisomerase gene. Bacteriophage T4 gene 39. Nucleic Acids Res (1986) 1.25
Replication of the broad host range plasmid RSF1010 in cell-free extracts of Escherichia coli and Pseudomonas aeruginosa. Nucleic Acids Res (1982) 1.23
Discriminatory function of ribonuclease H in the selective initiation of plasmid DNA replication. Nucleic Acids Res (1982) 1.20
Evidence that colicin X is microcin B17. J Bacteriol (1987) 1.04
Microcin B17, a novel tool for preparation of maxicells: identification of polypeptides encoded by the IncFII minireplicon pMccB17. J Bacteriol (1988) 0.97
DNA gyrase on the bacterial chromosome. Oxolinic acid-induced DNA cleavage in the dnaA-gyrB region. J Mol Biol (1988) 0.92
DNA topoisomerases as targets for chemotherapy. FASEB J (1988) 0.88
Pleiotropic mutations rendering Escherichia coli K-12 resistant to bacteriophage TP1. J Bacteriol (1980) 3.31
An E. coli promoter induced by the cessation of growth. Mol Microbiol (1987) 3.26
The export of the DNA replication inhibitor Microcin B17 provides immunity for the host cell. EMBO J (1988) 3.25
Induction of a growth-phase-dependent promoter triggers transcription of bolA, an Escherichia coli morphogene. EMBO J (1989) 2.86
Genetic analysis of bacteriophage phi 29 of Bacillus subtilis: integration and mapping of reference mutants of two collections. J Virol (1976) 2.38
Genetics of ribosomally synthesized peptide antibiotics. Annu Rev Microbiol (1992) 2.35
Induction of the SOS response by new 4-quinolones. J Antimicrob Chemother (1987) 2.31
Identification, cloning, and expression of bolA, an ftsZ-dependent morphogene of Escherichia coli. J Bacteriol (1988) 2.22
Bacillus subtilis phage phi29. Characterization of gene products and functions. Eur J Biochem (1976) 2.17
Growth phase and ompR regulation of transcription of microcin B17 genes. J Bacteriol (1986) 2.15
A novel deletion involving the connexin-30 gene, del(GJB6-d13s1854), found in trans with mutations in the GJB2 gene (connexin-26) in subjects with DFNB1 non-syndromic hearing impairment. J Med Genet (2005) 2.11
DNA sequence, products, and transcriptional pattern of the genes involved in production of the DNA replication inhibitor microcin B17. J Bacteriol (1989) 2.07
Suppressor-sensitive mutants and genetic map of Bacillus subtilis bacteriophage phi 29. Virology (1974) 2.01
A signal sequence is not sufficient to lead beta-galactosidase out of the cytoplasm. Nature (1980) 2.00
Cloning and mapping of the genetic determinants for microcin B17 production and immunity. J Bacteriol (1985) 1.90
Microcin B17 blocks DNA replication and induces the SOS system in Escherichia coli. J Gen Microbiol (1986) 1.89
Molecular analysis of the SMN and NAIP genes in Spanish spinal muscular atrophy (SMA) families and correlation between number of copies of cBCD541 and SMA phenotype. Hum Mol Genet (1996) 1.83
The DNA replication inhibitor microcin B17 is a forty-three-amino-acid protein containing sixty percent glycine. Proteins (1986) 1.80
Identification, mapping, cloning and characterization of a gene (sbmA) required for microcin B17 action on Escherichia coli K12. J Gen Microbiol (1986) 1.79
Ten novel mutations in the NR5A1 gene cause disordered sex development in 46,XY and ovarian insufficiency in 46,XX individuals. J Clin Endocrinol Metab (2012) 1.78
Chemical structure and translation inhibition studies of the antibiotic microcin C7. J Biol Chem (1995) 1.73
Gene ompR and regulation of microcin 17 and colicin e2 syntheses. J Bacteriol (1982) 1.70
Mutations in a new gene encoding a protein of the hair bundle cause non-syndromic deafness at the DFNB16 locus. Nat Genet (2001) 1.68
Lens injuries induced by occupational exposure in non-optimized interventional radiology laboratories. Br J Radiol (1998) 1.66
The transposon Tn5 carries a bleomycin-resistance determinant. Gene (1984) 1.65
The cyclic structure of microcin J25, a 21-residue peptide antibiotic from Escherichia coli. Eur J Biochem (1999) 1.64
Plasmid genes required for microcin B17 production. J Bacteriol (1985) 1.59
Sequence analysis of the four plasmid genes required to produce the circular peptide antibiotic microcin J25. J Bacteriol (1999) 1.57
An unusual mechanism for resistance to the antibiotic coumermycin A1. Proc Natl Acad Sci U S A (1991) 1.57
Transposition of the great arteries with posterior aorta, anterior pulmonary artery, subpulmonary conus and fibrous continuity between aortic and atrioventricular valves. Am J Cardiol (1971) 1.57
appR gene product activates transcription of microcin C7 plasmid genes. J Bacteriol (1989) 1.56
A genotype-phenotype correlation for GJB2 (connexin 26) deafness. J Med Genet (2004) 1.56
The colicin G, H and X determinants encode microcins M and H47, which might utilize the catecholate siderophore receptors FepA, Cir, Fiu and IroN. Microbiology (2003) 1.54
Cloning and mapping of the genetic determinants for microcin C7 production and immunity. J Bacteriol (1986) 1.53
Structure and organization of plasmid genes required to produce the translation inhibitor microcin C7. J Bacteriol (1995) 1.51
The Escherichia coli K-12 sheA gene encodes a 34-kDa secreted haemolysin. Mol Microbiol (1997) 1.45
The hexokinase 2 protein regulates the expression of the GLK1, HXK1 and HXK2 genes of Saccharomyces cerevisiae. Biochem J (2001) 1.44
Transcriptional regulation of the Saccharomyces cerevisiae HXK1, HXK2 and GLK1 genes. Yeast (1995) 1.42
mprA, an Escherichia coli gene that reduces growth-phase-dependent synthesis of microcins B17 and C7 and blocks osmoinduction of proU when cloned on a high-copy-number plasmid. J Bacteriol (1990) 1.42
Selective immediate allergic response to penicillin V. Allergy (1996) 1.41
dacD, an Escherichia coli gene encoding a novel penicillin-binding protein (PBP6b) with DD-carboxypeptidase activity. J Bacteriol (1996) 1.40
Splicing mutations of the polycystic kidney disease 1 (PKD1) gene induced by intronic deletion. Hum Mol Genet (1995) 1.39
Magnetic and electric coherence in forward- and back-scattered electromagnetic waves by a single dielectric subwavelength sphere. Nat Commun (2012) 1.39
The smallest known gene. Nature (1994) 1.38
Microcin H47, a chromosome-encoded microcin antibiotic of Escherichia coli. J Bacteriol (1990) 1.37
Genetic analysis of microcin H47 antibiotic system. J Bacteriol (1993) 1.34
Q829X, a novel mutation in the gene encoding otoferlin (OTOF), is frequently found in Spanish patients with prelingual non-syndromic hearing loss. J Med Genet (2002) 1.34
Changes in quality of life after renal transplantation. Am J Kidney Dis (1998) 1.31
Nucleotide sequence of the Escherichia coli regulatory gene mprA and construction and characterization of mprA-deficient mutants. J Bacteriol (1991) 1.30
A suppressor of nonsense mutations in Bacillus subtilis. Eur J Biochem (1974) 1.30
The centromere and promoter factor, 1, CPF1, of Saccharomyces cerevisiae modulates gene activity through a family of factors including SPT21, RPD1 (SIN3), RPD3 and CCR4. Mol Gen Genet (1993) 1.29
Evidence of linkage disequilibrium in the Spanish polycystic kidney disease I population. Am J Hum Genet (1994) 1.28
The ICL1 gene from Saccharomyces cerevisiae. Eur J Biochem (1992) 1.28
Identification of 14 novel mutations in the long isoform of USH2A in Spanish patients with Usher syndrome type II. J Med Genet (2006) 1.27
Heteroplasmy for the 1555A>G mutation in the mitochondrial 12S rRNA gene in six Spanish families with non-syndromic hearing loss. J Med Genet (2003) 1.23
The A1555G mutation in the 12S rRNA gene of human mtDNA: recurrent origins and founder events in families affected by sensorineural deafness. Am J Hum Genet (1999) 1.23
Hexokinase PII has a double cytosolic-nuclear localisation in Saccharomyces cerevisiae. FEBS Lett (1998) 1.18
Mitral atresia with normal aortic valve: a study of eighteen cases and a review of the literature. Circulation (1976) 1.18
The hexokinase 2 protein participates in regulatory DNA-protein complexes necessary for glucose repression of the SUC2 gene in Saccharomyces cerevisiae. FEBS Lett (1998) 1.16
Tpk3 and Snf1 protein kinases regulate Rgt1 association with Saccharomyces cerevisiae HXK2 promoter. Nucleic Acids Res (2006) 1.16
Hydrodynamic Maxwell demon in granular systems. Phys Rev E Stat Nonlin Soft Matter Phys (2001) 1.15
X chromosome-linked Kallmann syndrome: stop mutations validate the candidate gene. Proc Natl Acad Sci U S A (1992) 1.15
Mutations in the aphA-2 gene of transposon Tn5 mapping within the regions highly conserved in aminoglycoside-phosphotransferases strongly reduce aminoglycoside resistance. Mol Microbiol (1991) 1.08
sbmC, a stationary-phase induced SOS Escherichia coli gene, whose product protects cells from the DNA replication inhibitor microcin B17. Mol Microbiol (1995) 1.08
Mutation profile of the MYO7A gene in Spanish patients with Usher syndrome type I. Hum Mutat (2006) 1.07
DNA amplification fingerprinting for subtyping Neisseria gonorrhoeae strains. Sex Transm Dis (1995) 1.05
MYO7A mutation screening in Usher syndrome type I patients from diverse origins. J Med Genet (2007) 1.05
OmpC and LamB proteins can serve as substitute receptors for host range mutants of coliphage TuIa. J Bacteriol (1980) 1.04
Evidence that colicin X is microcin B17. J Bacteriol (1987) 1.04
Molecular forms of yeast invertase. Eur J Biochem (1975) 1.03
A cysteine substitution in the zona pellucida domain of alpha-tectorin results in autosomal dominant, postlingual, progressive, mid frequency hearing loss in a Spanish family. J Med Genet (2001) 1.03
Hemangiomas of the head, neck, and chest with associated vascular and brain anomalies: a complex neurocutaneous syndrome. AJNR Am J Neuroradiol (1996) 1.02
Functional characterization of transcriptional regulatory elements in the upstream region of the yeast GLK1 gene. Biochem J (1999) 1.01
Prospective study assessing hypoxia-related proteins as markers for the outcome of treatment with sunitinib in advanced clear-cell renal cell carcinoma. Ann Oncol (2013) 1.01
Use of serial carcinoembryonic antigen and CA 15.3 assays in detecting relapses in breast cancer patients. Breast Cancer Res Treat (1995) 0.99
Development of a molecular diagnostic test applied to experimental abattoir surveillance on bovine tuberculosis. Vet Microbiol (2007) 0.99
Patient dose reference levels for interventional radiology: a national approach. Cardiovasc Intervent Radiol (2008) 0.98
Invertase and alpha-galactosidase synthesis by yeast. Cell Mol Biol Incl Cyto Enzymol (1979) 0.98
A novel locus for non-syndromic sensorineural deafness (DFN6) maps to chromosome Xp22. Hum Mol Genet (1996) 0.97
Microcin B17, a novel tool for preparation of maxicells: identification of polypeptides encoded by the IncFII minireplicon pMccB17. J Bacteriol (1988) 0.97
Microcin-E492-insensitive mutants of Escherichia coli K12. J Gen Microbiol (1986) 0.97
Catabolite inactivation of isocitrate lyase from Saccharomyces cerevisiae. Arch Microbiol (1987) 0.96
Refining the localization of the PKD2 locus on chromosome 4q by linkage analysis in Spanish families with autosomal dominant polycystic kidney disease type 2. Am J Hum Genet (1995) 0.96
A novel locus for autosomal dominant nonsyndromic hearing loss, DFNA50, maps to chromosome 7q32 between the DFNB17 and DFNB13 deafness loci. J Med Genet (2004) 0.96
The hexokinase isoenzyme PII of Saccharomyces cerevisiae ia a protein kinase. J Gen Microbiol (1989) 0.96
Secretion of the Escherichia coli K-12 SheA hemolysin is independent of its cytolytic activity. FEMS Microbiol Lett (2001) 0.95
Molecular and clinical characterisation of three Spanish families with maternally inherited non-syndromic hearing loss caused by the 1494C->T mutation in the mitochondrial 12S rRNA gene. J Med Genet (2006) 0.95